MCK
McKesson Corporation · Healthcare · Medical - Distribution
Momentum inputs (comparable managers):
holder breadth -4.8% ·
share flow -0.7% ·
net new positions -5.0%
· formula
Broad distribution: falling shares and fewer holders
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q2 2025
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q3 2026 | 6 | 0 | 804.98K | $699.70M | n/a | n/a |
| Q2 2026 | 172 | 0 | 84.73M | $64.19B | +6 | −5 |
| Q1 2026 | 174 | 0 | 86.49M | $74.72B | +5 | −6 |
| Q4 2025 | 173 | +2 | 91.21M | $74.82B | +3 | n/a |
| Q3 2025 | 22 | 0 | 48.07M | $37.12B | +1 | −2 |
| Q2 2025 | 20 | -1 | 40.25M | $29.48B | n/a | −1 |
| Q1 2025 | 18 | -1 | 15.05M | $10.13B | +1 | −2 |
| Q4 2024 | 19 | +1 | 15.70M | $8.94B | +1 | n/a |
| Q3 2024 | 17 | -1 | 9.08M | $4.48B | +1 | −2 |
| Q2 2024 | 18 | n/a | 11.69M | $6.82B | n/a | n/a |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | The Vanguard Group ✦ (passive) | 12.07M | n/a | $8.85B | 0.1% | n/c | 1 | SEC ↗ ×6 |
| 2 | BlackRock ✦ (passive) | 11.25M | n/a | $8.24B | 0.2% | n/c | 1 | SEC ↗ ×22 |
| 3 | State Street Global Advisors ✦ (passive) | 5.70M | +0.1% | $4.18B | 0.2% | ▲ Add | 3 | SEC ↗ |
| 4 | Geode Capital Management ✦ (passive) | 2.82M | +4.1% | $2.06B | 0.1% | ▲ Add | 5 | SEC ↗ ×2 |
| 5 | Fidelity (FMR) ✦ | 2.15M | n/a | $1.57B | 0.1% | n/c | 1 | SEC ↗ ×6 |
| 6 | Norges Bank ✦ (passive) | 1.84M | +4.1% | $1.35B | 0.2% | ▲ Add | 5 | SEC ↗ |
| 7 | Arrowstreet Capital ✦ | 1.24M | +56.4% | $906.11M | 0.6% | ▲ Add | 5 | SEC ↗ |
| 8 | T. Rowe Price ✦ | 899.84K | -30.2% | $659.39M | 0.1% | ▼ Trim | 5 | SEC ↗ ×2 |
| 9 | AQR Capital Management ✦ | 855.70K | -10.4% | $620.81M | 0.5% | ▼ Trim | 5 | SEC ↗ ×8 |
| 10 | Wellington Management ✦ | 465.80K | +8.9% | $341.33M | 0.1% | ▲ Add | 5 | SEC ↗ ×9 |
| 11 | Two Sigma Investments ✦ | 289.43K | -11.2% | $212.09M | 0.4% | ▼ Trim | 5 | SEC ↗ |
| 12 | Renaissance Technologies ✦ | 198.13K | +24665.8% | $145.18M | 0.2% | ▲ Add | 4 | SEC ↗ |
| 13 | Adage Capital Partners ✦ | 149.77K | -31.3% | $109.75M | 0.2% | ▼ Trim | 5 | SEC ↗ |
| 14 | Bridgewater Associates ✦ | 147.77K | -5.4% | $108.28M | 0.4% | ▼ Trim | 5 | SEC ↗ |
| 15 | D. E. Shaw & Co. ✦ | 100.42K | +29.2% | $73.59M | 0.1% | ▲ Add | 5 | SEC ↗ ×2 |
| 16 | Gotham Asset Management ✦ | 36.51K | +36.4% | $26.75M | 0.2% | ▲ Add | 5 | SEC ↗ |
| 17 | Glenview Capital ✦ | 25.58K | -68.7% | $18.75M | 0.5% | ▼ Trim | 5 | SEC ↗ |
| 18 | Marshall Wace ✦ | 12.52K | -96.8% | $9.18M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 19 | Millennium Management ✦ | 4.77K | -96.2% | $3.50M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 20 | Fisher Asset Management ✦ | 1.02K | +1.3% | $746,256 | 0.0% | ▲ Add | 5 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value: the conviction measure. ✦ = curated manager.
New buyers
| No new tracked buyers this quarter. |
Exited
| Soros Fund Management | $10.09M | was 0.3% |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 2,017 holders, 102.83M shares, $85.35B reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold: shared-ownership counts, not fundamental relationships.
Open-market purchases (P)
No open-market insider purchases in our coverage window.
Open-market sales (S)
Officer · 800 sh · $797,129
Officer · 111 sh · $98,951
Director · 301 sh · $268,590
Awards, exercises and tax withholding are never counted as buys or sales here. Methodology